Drug Nomenclature Monographs
Drug Nomenclature Monographs | Monograph Number |
---|---|
Drug Classification | C-DRG-00101 |
Dosage Form | C-DRG-00201 (FDA Archive) |
Route of Administration | C-DRG-00301 |
Ingredient Name | C-DRG-00401 |
Proprietary Name | C-DRG-00402 (FDA Archive) |
Animal Common Names | C-DRG-00403 (FDA Archive) |
Animal Cell Tissue Fluid Biomolecule | C-DRG-00404 (FDA Archive) |
Biotechnology Origin | C-DRG-00405 (FDA Archive) |
Potency | C-DRG-00501 |
Indications | C-DRG-00601 (FDA Archive) |
Therapeutic Equivalence Code | C-DRG-00701 (FDA Archive) |
Phase 4 Commitment Category | C-DRG-00901 |
Phase 4 Fulfillment Category | C-DRG-00902 (FDA Archive) |
Pediatric use Supplement Rule | C-DRG-00903 (FDA Archive) |
Pediatric Use Supplement Clinical Efficacy Trials Category | C-DRG-00904 (FDA Archive) |
Pediatric Use Supplement PK/PD Category | C-DRG-00905 (FDA Archive) |
Pediatric Use Supplement Safety/Adverse Reaction Category | C-DRG-00906 (FDA Archive) |
Package Type | C-DRG-00907 |
Pediatric Exclusivity Study Type | C-DRG-00908 (FDA Archive) |
Pediatric Exclusivity Study Age Group | C-DRG-00909 |
Pediatric Exclusivity Study Basis | C-DRG-00910 (FDA Archive) |
Pediatric Exclusivity Study Drug List | C-DRG-00911 (FDA Archive) |
Geriatric Use Supplement Rule | C-DRG-00913 (FDA Archive) |
Geriatric Use Supplement Clinical Efficacy Trials Category | C-DRG-00914 (FDA Archive) |
Geriatric Use Supplement PK/PD Category | C-DRG-00915 (FDA Archive) |
Geriatric Use Supplement Safety/Adverse Reaction Category | C-DRG-00916 (FDA Archive) |
Industry Meeting Type | C-DRG-00917 |
Industry Meeting Response | C-DRG-00918 (FDA Archive) |
PACT Commitment Category | C-DRG-00919 (FDA Archive) |
PACT Fulfillment Category | C-DRG-00920 (FDA Archive) |
Global Suplement Status | C-DRG-00921 (FDA Archive) |
Plant Part | C-DRG-00924 (FDA Archive) |
SPL Coating | C-DRG-0925 (FDA Archive) |
SPL Symbol | C-DRG-0926 (FDA Archive) |
SPL Color | C-DRG-0927 |
SPL Size | C-DRG-0928 (FDA Archive) |
SPL Shape | C-DRG-0929 |
SPL Score | C-DRG-0930 (FDA Archive) |
SPL Imprint | C-DRG-0931 (FDA Archive) |
SPL Image | C-DRG-0932 (FDA Archive) |
SPL DEA Schedule | C-DRG-0933 |
SPL Flavor | C-DRG-0934 (FDA Archive) |
Marketing Category | C-DRG-0935 |